We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$51.2B
AUM Growth
+$4.14B
(+8.8%)
Cap. Flow
+$445M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.99B |
| 2 |
Microsoft
MSFT
|
+$522M |
| 3 |
Advanced Micro Devices
AMD
|
+$511M |
| 4 |
Amazon
AMZN
|
+$318M |
| 5 |
Apple
AAPL
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$402M |
| 2 |
McDonald's
MCD
|
+$375M |
| 3 |
Visa
V
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$319M |
| 5 |
Adobe
ADBE
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 17.11% |
| 3 | Consumer Discretionary | 13.31% |
| 4 | Financials | 8% |
| 5 | Industrials | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
LeMaitre Vascular
LMAT
$1.86B
| $4.25M | 0.01% |
+63,234
| New | +$3.86M |
|
1077
Five Below
FIVE
$13.5B
| $4.24M | 0.01% |
21,561
-9,099
| -30% | -$1.78M |
|
|
PRLHW
1078
CALL
DELISTED
Pearl Holdings Acquisition Corp Warrant
PRLHW
| $4.22M | 0.01% |
399,206
-906
| -0.2% | -$83 |
|
1079
Ralph Lauren
RL
$23.6B
| $4.21M | 0.01% |
34,173
-361,381
| -91% | -$41.7M |
|
1080
CAE Inc. Common Shares
CAE
$8.74B
| $4.19M | 0.01% |
+187,022
| New | +$4.14M |
|
1081
Corcept Therapeutics
CORT
$12B
| $4.17M | 0.01% |
187,626
+65,500
| +54% | +$1.51M |
|
|
BLEUR
1082
CALL
DELISTED
bleuacacia ltd Rights
BLEUR
| $4.16M | 0.01% |
400,000
| – | – |
|
|
WW
1083
DELISTED
WW International
WW
| $4.15M | 0.01% |
617,969
-67,722
| -10% | -$480K |
|
1084
Brink's
BCO
$4.62B
| $4.15M | 0.01% |
61,175
+4,726
| +8% | +$316K |
|
1085
Trex
TREX
$5.01B
| $4.11M | 0.01% |
62,733
+35,091
| +127% | +$1.96M |
|
1086
Vicor
VICR
$10.2B
| $4.11M | 0.01% |
76,089
+58,210
| +326% | +$2.87M |
|
1087
Magnachip Semiconductor
MX
$145M
| $4.1M | 0.01% |
366,371
+291,182
| +387% | +$2.85M |
|
1088
PUT
Pfizer
PFE
$153B
| $4.06M | 0.01% |
110,700
+20,800
| +23% | +$810K |
|
1089
CALL
Chevron
CVX
$366B
| $4.06M | 0.01% |
25,800
+17,300
| +204% | +$2.77M |
|
1090
Pultegroup
PHM
$25.3B
| $4.06M | 0.01% |
52,250
-46,776
| -47% | -$3.17M |
|
1091
iShares MSCI Mexico ETF
EWW
$1.92B
| $4.06M | 0.01% |
+65,227
| New | +$3.99M |
|
1092
Surgery Partners
SGRY
$2.03B
| $4.05M | 0.01% |
+89,985
| New | +$3.43M |
|
1093
Turning Point Brands
TPB
$1.74B
| $4.03M | 0.01% |
167,904
-114,220
| -40% | -$2.57M |
|
1094
Tecnoglass Holdings Inc.
TGLS
$1.96B
| $4M | 0.01% |
77,488
+67,420
| +670% | +$3M |
|
1095
CALL
Broadcom
AVGO
$2.04T
| $3.99M | 0.01% |
46,000
+30,000
| +188% | +$2.14M |
|
1096
Westamerica Bancorp
WABC
$1.37B
| $3.97M | 0.01% |
103,648
+8,742
| +9% | +$350K |
|
|
SFBS
1097
ServisFirst Bancshares
SFBS
$4.86B
| $3.94M | 0.01% |
96,407
+21,890
| +29% | +$1.01M |
|
1098
CALL
Bank of America
BAC
$442B
| $3.94M | 0.01% |
137,200
-206,600
| -60% | -$5.9M |
|
|
BFAC.WS
1099
CALL
DELISTED
Battery Future Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
BFAC.WS
| $3.93M | 0.01% |
370,975
-32,185
| -8% | -$2.83K |
|
|
ACAHW
1100
CALL
DELISTED
Atlantic Coastal Acquisition Corp. Warrant
ACAHW
| $3.93M | 0.01% |
361,421
-100,000
| -22% | -$5.01K |
|
Similar funds
Marshall Wace's Q2 2023 Portfolio in Review
As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace's Q2 2023 filing shows 648 new, 710 increased, 838 reduced and 835 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B. The largest sale was Gilead Sciences, an estimated $402M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
- Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
- Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
- Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
- Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
- Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.
Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.